Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Vision Holdings (EYE) Raw Materials (2016 - 2026)

National Vision Holdings' Raw Materials history spans 11 years, with the latest figure at $65.8 million for Q1 2026.

  • On a quarterly basis, Raw Materials changed 0.43% to $65.8 million in Q1 2026 year-over-year; TTM through Jan 2026 was $65.8 million, a 0.43% change, with the full-year FY2026 number at $65.8 million, changed 0.43% from a year prior.
  • Raw Materials hit $65.8 million in Q1 2026 for National Vision Holdings, up from $62.9 million in the prior quarter.
  • Over the last five years, Raw Materials for EYE hit a ceiling of $66.1 million in Q4 2024 and a floor of $55.5 million in Q1 2024.
  • Historically, Raw Materials has averaged $61.2 million across 5 years, with a median of $62.0 million in 2023.
  • Biggest five-year swings in Raw Materials: grew 17.65% in 2022 and later dropped 11.45% in 2023.
  • Tracing EYE's Raw Materials over 5 years: stood at $64.8 million in 2022, then fell by 11.45% to $57.4 million in 2023, then rose by 15.15% to $66.1 million in 2024, then fell by 4.84% to $62.9 million in 2025, then increased by 4.64% to $65.8 million in 2026.
  • Business Quant data shows Raw Materials for EYE at $65.8 million in Q1 2026, $62.9 million in Q3 2025, and $61.4 million in Q2 2025.